Award to honour excellence in gynaecological cancers

Release Date: 

22/02/2016

News Type: 

  • Media Releases

Cancer Australia is pleased to announce that nominations for the 2016 Jeannie Ferris Cancer Australia Recognition Award open on the eve of Teal Ribbon Day, Tuesday 23 February 2016. 

This year, it is expected that 15 women will be diagnosed with a gynaecological cancer every day. 

CEO of Cancer Australia, Professor Helen Zorbas said, “The Jeannie Ferris Cancer Australia Recognition Award honours those who are working to help improve outcomes for women affected by gynaecological cancer, and recognises the exceptional efforts made by members of the community, health professionals and researchers.

“I am once again delighted to call for nominations.”

Nominations open this year in the context of Teal Ribbon Day, a day to raise awareness of ovarian cancer, which remains the most common cause of gynaecological cancer death in Australia. 

The Jeannie Ferris Cancer Australia Recognition Award is offered in two categories:

The first is open to those with personal experience of gynaecological cancer, as a woman with a diagnosis of gynaecological cancer; a community or family member; or carers who have been directly involved in the support and care of a woman with gynaecological cancer.

The second category is open to health professionals and researchers working in the area of gynaecological cancer.

The Jeannie Ferris Cancer Australia Recognition Award was established by Cancer Australia in 2013 and is named in honour of the late Jeannie Ferris, former Senator for South Australia.  Senator Ferris passed away in April 2007 after being diagnosed with ovarian cancer in October 2005, and was passionate about raising awareness and increasing research for all gynaecological cancers. 

Nominations open on Tuesday 23 February 2016, and will close at 5:00pm on Thursday 31 March 2016 (EDST).  For further information and to view the selection criteria click here.

Gynaecological cancer is an overarching term used to describe cancer of the ovaries, uterus, cervix, vagina and vulva, as well as, the fallopian tube and placenta (a pregnancy related cancer).